INM
Price
$4.95
Change
+$0.45 (+10.00%)
Updated
Jan 17 closing price
Capitalization
3.58M
VTYX
Price
$2.02
Change
+$0.13 (+6.88%)
Updated
Jan 17 closing price
Capitalization
142.84M
61 days until earnings call
Ad is loading...

INM vs VTYX

Header iconINM vs VTYX Comparison
Open Charts INM vs VTYXBanner chart's image
InMed Pharmaceuticals
Price$4.95
Change+$0.45 (+10.00%)
Volume$39.84K
Capitalization3.58M
Ventyx Biosciences
Price$2.02
Change+$0.13 (+6.88%)
Volume$2.28M
Capitalization142.84M
INM vs VTYX Comparison Chart
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. VTYX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and VTYX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (INM: $4.95 vs. VTYX: $2.02)
Brand notoriety: INM and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 122% vs. VTYX: 115%
Market capitalization -- INM: $3.58M vs. VTYX: $142.84M
INM [@Biotechnology] is valued at $3.58M. VTYX’s [@Biotechnology] market capitalization is $142.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, both INM and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 2 TA indicator(s) are bullish while VTYX’s TA Score has 2 bullish TA indicator(s).

  • INM’s TA Score: 2 bullish, 5 bearish.
  • VTYX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, INM is a better buy in the short-term than VTYX.

Price Growth

INM (@Biotechnology) experienced а +14.85% price change this week, while VTYX (@Biotechnology) price change was -2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

INM is expected to report earnings on Nov 14, 2024.

VTYX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($143M) has a higher market cap than INM($3.59M). INM YTD gains are higher at: 7.843 vs. VTYX (-7.763). INM has higher annual earnings (EBITDA): -6.66M vs. VTYX (-164.94M). VTYX has more cash in the bank: 275M vs. INM (5.58M). INM has less debt than VTYX: INM (1.06M) vs VTYX (11M). INM has higher revenues than VTYX: INM (4.96M) vs VTYX (0).
INMVTYXINM / VTYX
Capitalization3.59M143M3%
EBITDA-6.66M-164.94M4%
Gain YTD7.843-7.763-101%
P/E Ratio0.02N/A-
Revenue4.96M0-
Total Cash5.58M275M2%
Total Debt1.06M11M10%
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMVTYX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
89%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
88%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 23 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
View a ticker or compare two or three
Ad is loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMAFX11.100.08
+0.73%
American Century Small Cap Dividend I
GMOIX25.030.14
+0.56%
GMO International Equity III
GLRIX22.160.10
+0.45%
James Balanced: Golden Rainbow Instl
ANOHX25.280.08
+0.32%
American Century Small Cap Growth G
GIEZX13.90N/A
N/A
GuideStone Funds International Eq Inv

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TFFP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TFFP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
+10.00%
TFFP - INM
53%
Loosely correlated
N/A
TTNP - INM
48%
Loosely correlated
+21.94%
EYEN - INM
39%
Loosely correlated
-5.15%
OMER - INM
36%
Loosely correlated
+1.63%
VTYX - INM
31%
Poorly correlated
+6.88%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with IOVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+6.88%
IOVA - VTYX
44%
Loosely correlated
+2.60%
AKRO - VTYX
38%
Loosely correlated
+4.71%
RAPT - VTYX
38%
Loosely correlated
+0.84%
PYPD - VTYX
37%
Loosely correlated
+3.45%
DYN - VTYX
36%
Loosely correlated
-4.33%
More